Emergent Health Corp. (“Emergent”) (OTC PINK:EMGE) announces it has executed a Letter of Intent to acquire Evolutionary Biologics, Inc. Biologics, Inc. is a new type of biologics company with a specific mission: to provide the medical community with cutting-edge regenerative therapies. The final purchase price, which will be negotiated by the Parties, will include the issuance of equity in Emergent (OTC PINK:EMGE) and defined capital investment into Evolutionary Biologics for sales, scaling of company operations, and promotions, all based on projections, and subject to funding, as negotiated and agreed upon by Emergent (OTC PINK:EMGE) and Evolutionary. The products of Evolutionary Biologics include Evo Hybrid and HydrEyes. Evo Hybrid stimulates your body’s inherent healing ability to help restore your skin’s youthful elasticity.HydrEyes reduces redness to reveal the natural radiance of your eyes.
The mission of Evolutionary Biologics is to raise consumer awareness of regenerative medicine through a global presence and the application of science and technology to the development of cosmetic products. Evolutionary Biologics plans to utilize push and pull marketing, social media, and consumer awareness events to establish partnerships with clinics for their product.
Fusion Specialty Pharmacies, nationally accredited compounding pharmacies licensed in 27 states and located in St. George, Utah committed to formulating creative, individualized, and compounded medications that can improve compliance, maximize the potential for therapeutic success, and reduce the overall cost of healthcare (“Fusion”) and Regen Biowellness, a distributor of viscus health products, will be acquired. Jim Morrison, president, and chief executive officer of Evolutionary Biologics, said, Both Emergent (OTC PINK:EMGE) Health and Evolutionary Biologics will be able to advance their respective businesses in the modern medical market as a result of their union. It also positions Emergent OTC PINK:EMGE) Health as an industry leader in plant-based wellness and regenerative health.
James W. Zimbler, the chief executive officer of Emergent, explained that, With the planned introduction and addition of Evolutionary Biologics to Emergent Health (OTC PINK:EMGE), it takes our goals and plans for regenerative care to a new level and furthers our plans to make Emergent Health (OTC PINK:EMGE) a premier health and wellness company, giving Emergent another avenue to reach consumers.
ABOUT EMERGENT HEALTH COMPANY
Emergent Health Corporation (OTC PINK:EMGE) is creating a product line in the domains of Regenerative Medicine, enhanced neutraceuticals, and phytonutritionals that will be offered without a prescription to the general population. Its products include both ingestible and topicals for the entire family. Utilizing Influencers to position products in their produced content, the company distributes its products online and through content-based shopping throughout the United States and beyond. PharmaZu, its newly acquired company, is a pure-play, e-commerce products and services provider focusing on the pet community, pet pharmacy, and wellness by using Influencers and their content, including the pet pharmacy, vet telemedicine, and pet wellness businesses. Emergent (OTC PINK:EMGE) does not assert that any of its products are FDA-approved to diagnose, treat, cure, or prevent disease. Always with your Veterinarian and Family Physician before utilizing any product.
Featured Image: Megapixl @bialasiewicz
